Aspen has also moved to consolidate its operations, selling Strides a 51% stake of its UK business, Co-pharma, and an 80% slice of its South African vitamin and supplements business, Formula Naturelle ... Commodity generics are sold unbranded. The Co-pharma deal is worth £2,6m, while the Formula Naturelle agreement carries a R35m price tag ... .
By SLINDILE KHANYILE ...Aspen will pay $152.5 million (R1 billion) for the business which operates mainly in Brazil, Mexico and Venezuela ... Saad said ... Strides has bought 51 percent of the Aspen UK unit Co-pharma for 230 million rupees (R39.3 million) and 80 percent in its Formula Naturelle division for 197 million rupees ... The sector lost 0.99 percent. .
Strides' acquisition of a 51 percent stake in Aspen's UK subsidiary Co-pharma Limited; and. Strides' acquisition of 80 percent of the equity in Formula Naturelle which will, in turn, own a basket of nutraceutical products currently marketed by Aspen Pharmacare in South Africa.